Print this article Email this article

| Add RSS Feed

January 3, 2008 -- Microchip Biotechnologies Inc. (MBI) has been selected for participation in the inaugural U.S. Army Commercialization Pilot Program, the company announced in a news release.

The program identifies firms with Phase II Small Business Innovation Research (SBIR) projects that have a high potential of transitioning to commercial products that meet high-priority Army requirements.

Microchip Biotechnologies was one of 25 firms selected out of 529 eligible and 416 applicants.

MBI has been developing a microfluidic-based biothreat detection system under Army SBIR funding.

| Add RSS Feed

---

More Defense Articles >

Search Archives >

Small Times Article Categories:

Photonics		Profiles
Environment		Manufacturing
Finance		Research and Development
Education		Bio
Consumer		Defense
Energy		Electronics
Auto/Aero		Legal
Materials		Tools
Small Times Current Issue Table of Contents

---

Search Products Buyer's Guide >

Search Industry Jobs >

Magazine & E-Newsletter Subscriptions >